Gros1 activators encompass a diverse array of chemical compounds that indirectly influence the functional activity of Gros1 through modulation of various signaling pathways and cellular processes. Compounds like Forskolin and Ionomycin act by elevating intracellular levels of cAMP and calcium, respectively, which could enhance Gros1 activity through the activation of protein kinases such as PKA and calcium-dependent kinases. These kinases may phosphorylate substrates within signaling pathways involving Gros1, thus indirectly augmenting its activity. Similarly, PMA activates protein kinase C (PKC), potentially leading to the phosphorylation of proteins in pathways that regulate Gros1 activity, thereby enhancing its role in cellular signaling. Inhibitors such as U0126 and LY294002 modulate the MAPK/ERK and PI3K/Akt pathways, respectively, creating shifts in cellular signaling that could favor Gros1 activation, assuming Gros1 interacts with or is part of these pathways.
Additionally, compounds like Resveratrol and Curcumin offer antioxidant properties and modulate NF-κB signaling, potentially supporting Gros1 activity by influencing pathways linked to oxidative stress responses or inflammation. This modulation could indirectly enhance Gros1's functional role in cellular health and immune responses. Epigallocatechin Gallate (EGCG) and Sildenafil Citrate further contribute to the activation of Gros1 by affecting multiple signaling mechanisms, including those related to NF-κB, Akt, ERK, and cGMP, suggesting that changes in these pathways could lead to enhanced Gros1 activity. Metformin and Sodium Butyrate, acting through AMPK activation and histone deacetylase inhibition, respectively, illustrate the complex interplay between metabolism, epigenetics, and signaling pathways in regulating Gros1 activity, highlighting the potential of diverse chemical compounds to indirectly activate Gros1 through multifaceted biological processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Enhances Gros1 activity by elevating intracellular cAMP levels, which can lead to the activation of PKA. PKA then potentially phosphorylates proteins that are part of the signaling pathway involving Gros1, indirectly increasing Gros1 functional activity by enhancing its signaling capacity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Acts by increasing intracellular calcium levels, which could activate calcium-dependent kinases that modulate Gros1 activity. The elevation of calcium could stimulate signaling pathways that Gros1 is a part of, leading to its enhanced activity through calcium-mediated signaling events. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC, which could be involved in the signaling pathways that regulate Gros1 activity. Activation of PKC may lead to the phosphorylation of proteins that interact with Gros1, potentially enhancing Gros1's functional role in its respective signaling pathway. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK1/2, leading to alterations in the MAPK/ERK pathway that could indirectly influence Gros1 activity. By modulating this pathway, U0126 may shift cellular signaling dynamics in a way that enhances the activity or expression of Gros1 through reduced negative feedback. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, affecting the PI3K/Akt signaling pathway, which is often involved in cell survival and proliferation. This inhibition can lead to adjustments in cellular responses that indirectly enhance Gros1 activity, assuming Gros1 is part of or interacts with components of this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that could modulate stress response pathways potentially linked to Gros1 activity. By inhibiting p38, SB203580 might alter the cellular stress response in a manner that indirectly increases Gros1 activity, especially if Gros1 is involved in responding to cellular stress. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Acts as an antioxidant and sirtuin activator, which might support Gros1 activity by modulating oxidative stress responses or energy metabolism pathways Gros1 is potentially involved in. Enhanced cellular health and reduced oxidative damage could indirectly support Gros1's functional role. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Modulates NF-κB signaling, potentially affecting Gros1 activity if Gros1 is linked to inflammation or immune response pathways. By influencing NF-κB pathway activity, Curcumin could indirectly enhance Gros1's role in these processes. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Affects multiple signaling pathways including NF-κB, Akt, and ERK, which could indirectly enhance Gros1 activity by modulating cellular signaling landscapes in which Gros1 operates, leading to its increased activity through a broad spectrum of signaling modifications. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Activates AMPK, which could influence Gros1 activity if Gros1 is involved in metabolic regulation or energy homeostasis. By modulating AMPK activity, Metformin may indirectly enhance the functional role of Gros1 in these pathways. | ||||||